The eliciting dose of peanut in double-blind, placebo-controlled food challenges decreases with increasing age and specific IgE level in children and young adults.

@article{Zee2011TheED,
  title={The eliciting dose of peanut in double-blind, placebo-controlled food challenges decreases with increasing age and specific IgE level in children and young adults.},
  author={Tjitske van der Zee and Anthony T Dubois and M Kerkhof and Sicco van der Heide and Berber J. Vlieg-Boerstra},
  journal={The Journal of allergy and clinical immunology},
  year={2011},
  volume={128 5},
  pages={1031-6}
}
BACKGROUND Several risk factors for severe anaphylactic reactions to food in daily life are known. However, to date, it is not possible to predict the severity of allergic reactions to food in the individual patient with accuracy. Some studies show that a history of severe reactions is associated with a lower eliciting dose in double-blind, placebo-controlled food challenges (DBPCFCs). Therefore, in this study, the eliciting dose was used as a measure of clinical sensitivity. OBJECTIVES To… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 3 times. VIEW TWEETS

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 16 extracted citations

Apolipoprotein B: a possible new biomarker for anaphylaxis.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology • 2017

Peanut-allergic patients in the MIRABEL survey: characteristics, allergists' dietary advice and lessons from real life.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology • 2016

Objective eliciting doses of peanut-allergic adults and children can be combined for risk assessment purposes.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology • 2015
View 2 Excerpts

Similar Papers

Loading similar papers…